EP3911337A4 - Compositions à base de pétrolatum et méthodes de traitement de l'onychomycose - Google Patents

Compositions à base de pétrolatum et méthodes de traitement de l'onychomycose Download PDF

Info

Publication number
EP3911337A4
EP3911337A4 EP20741114.1A EP20741114A EP3911337A4 EP 3911337 A4 EP3911337 A4 EP 3911337A4 EP 20741114 A EP20741114 A EP 20741114A EP 3911337 A4 EP3911337 A4 EP 3911337A4
Authority
EP
European Patent Office
Prior art keywords
methods
treating onychomycosis
petrolatum compositions
petrolatum
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP20741114.1A
Other languages
German (de)
English (en)
Other versions
EP3911337A1 (fr
Inventor
Bradley BURNAM
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Global Health Solutions LLC
Original Assignee
Global Health Solutions LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Global Health Solutions LLC filed Critical Global Health Solutions LLC
Publication of EP3911337A1 publication Critical patent/EP3911337A1/fr
Publication of EP3911337A4 publication Critical patent/EP3911337A4/fr
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/14Quaternary ammonium compounds, e.g. edrophonium, choline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/4174Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41961,2,4-Triazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4418Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/53751,4-Oxazines, e.g. morpholine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP20741114.1A 2019-01-16 2020-01-16 Compositions à base de pétrolatum et méthodes de traitement de l'onychomycose Pending EP3911337A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962793317P 2019-01-16 2019-01-16
PCT/US2020/013959 WO2020150531A1 (fr) 2019-01-16 2020-01-16 Compositions à base de pétrolatum et méthodes de traitement de l'onychomycose

Publications (2)

Publication Number Publication Date
EP3911337A1 EP3911337A1 (fr) 2021-11-24
EP3911337A4 true EP3911337A4 (fr) 2022-10-26

Family

ID=71613212

Family Applications (1)

Application Number Title Priority Date Filing Date
EP20741114.1A Pending EP3911337A4 (fr) 2019-01-16 2020-01-16 Compositions à base de pétrolatum et méthodes de traitement de l'onychomycose

Country Status (5)

Country Link
EP (1) EP3911337A4 (fr)
JP (1) JP2022522991A (fr)
BR (1) BR112021014073A2 (fr)
CA (1) CA3127052A1 (fr)
WO (1) WO2020150531A1 (fr)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016126982A1 (fr) * 2015-02-05 2016-08-11 Marc Selner Suspension de nano-vésicules ioniques et biocide préparé à partir d'une telle suspension
US20160271121A1 (en) * 2015-03-16 2016-09-22 Gavis Pharmaceuticals Antifungal combination therapy
US20170333346A1 (en) * 2015-06-19 2017-11-23 Global Health Solutions Llc Petrolatum-based delivery systems and for active ingredients

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1355699A (zh) * 1999-04-16 2002-06-26 藤泽药品工业株式会社 抗真菌组合物
JP2004083439A (ja) * 2002-08-23 2004-03-18 Ss Pharmaceut Co Ltd 爪用抗真菌外用剤
US8039494B1 (en) * 2010-07-08 2011-10-18 Dow Pharmaceutical Sciences, Inc. Compositions and methods for treating diseases of the nail
WO2013149190A1 (fr) * 2012-03-30 2013-10-03 Wu Nian Compositions pharmaceutiques et méthodes pour le traitement d'infections fongiques

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016126982A1 (fr) * 2015-02-05 2016-08-11 Marc Selner Suspension de nano-vésicules ioniques et biocide préparé à partir d'une telle suspension
US20160271121A1 (en) * 2015-03-16 2016-09-22 Gavis Pharmaceuticals Antifungal combination therapy
US20170333346A1 (en) * 2015-06-19 2017-11-23 Global Health Solutions Llc Petrolatum-based delivery systems and for active ingredients

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2020150531A1 *

Also Published As

Publication number Publication date
CA3127052A1 (fr) 2020-07-23
WO2020150531A1 (fr) 2020-07-23
EP3911337A1 (fr) 2021-11-24
JP2022522991A (ja) 2022-04-21
BR112021014073A2 (pt) 2021-09-28

Similar Documents

Publication Publication Date Title
EP3924481A4 (fr) Compositions et méthodes de traitement d'hémoglobinopathies
EP3959318A4 (fr) Compositions d'oligonucléotides et leurs méthodes d'utilisation
EP3920923A4 (fr) Agents thérapeutiques et méthodes de traitement
EP3965832A4 (fr) Compositions et méthodes de traitement de l'hépatite b
EP3976595A4 (fr) Composés de 1-oxo-isoindoline-5-carboxamide substitués, compositions de ceux-ci, et procédés de traitement associés
EP3775263A4 (fr) Compositions et méthodes de traitement de l'acné
EP4337203A4 (fr) Inhibiteurs de l'interaction ménine-mll
EP4319751A4 (fr) Compositions thérapeutiques et méthodes de traitement de tumeurs
EP3856214A4 (fr) Compositions microbiennes et méthodes d'utilisation
EP3843524A4 (fr) Composition de traitement des semences et procédé d'utilisation
EP4284417A4 (fr) Compositions et méthodes de traitement de l'angi?dème héréditaire
FR25C1007I1 (fr) Formulations d'épinéphrine intranasale et méthodes de traitement d'une maladie
MA55532A (fr) Composés de neuréguline-4 et procédés d'utilisation
EP4100127A4 (fr) Méthodes de traitement de la sclérodermie et d'états associés
EP3843700A4 (fr) Compositions et méthodes de soins dentaires
EP4326277A4 (fr) Méthodes de traitement de strictions d'sophagiennes
EP4232041A4 (fr) Méthodes de traitement de tauopathies à 4 répétitions
EP3996712A4 (fr) Compositions et procédés destinés au traitement de la démence à corps de lewy
EP4135760A4 (fr) Compositions et méthodes de traitement de la leucémie
EP4100430A4 (fr) Compositions et méthodes de traitement de l'hypertension pulmonaire
EP4037696A4 (fr) Compositions et méthodes de traitement de la maladie d'alzheimer
EP4384220A4 (fr) Compositions et méthodes de traitement du cancer
EP3781945A4 (fr) Compositions et méthodes de traitement de l'endométriose
EP4007610A4 (fr) Compositions et méthodes de traitement d' alpha-thalassémie
EP3911337A4 (fr) Compositions à base de pétrolatum et méthodes de traitement de l'onychomycose

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20210816

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20220927

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 8/34 20060101ALI20220921BHEP

Ipc: A61K 8/22 20060101ALI20220921BHEP

Ipc: A61K 47/10 20170101ALI20220921BHEP

Ipc: A61K 33/40 20060101AFI20220921BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20250219